ANAB
Anaptysbio, Inc.
Clinical-stage biotechnology company focused on immunology therapeutics
CUSIP: 032724106HealthcareUS1 holder
Total Value
$60.85M
Total Shares
609.9K
Net Share Change
+66.1K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$60.85M609.9K shares
ADD+66.1K(+12.2%)